Lifecore Biomedical Stock Alpha and Beta Analysis
| LFCR Stock | 6.98 0.50 6.68% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Lifecore Biomedical. It also helps investors analyze the systematic and unsystematic risks associated with investing in Lifecore Biomedical over a specified time horizon. Remember, high Lifecore Biomedical's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Lifecore Biomedical's market risk premium analysis include:
Beta 1.39 | Alpha 0.35 | Risk 6.14 | Sharpe Ratio 0.0563 | Expected Return 0.35 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Lifecore |
Lifecore Biomedical Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Lifecore Biomedical market risk premium is the additional return an investor will receive from holding Lifecore Biomedical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Lifecore Biomedical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Lifecore Biomedical's performance over market.| α | 0.35 | β | 1.39 |
Lifecore Biomedical expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Lifecore Biomedical's Buy-and-hold return. Our buy-and-hold chart shows how Lifecore Biomedical performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Lifecore Biomedical Market Price Analysis
Market price analysis indicators help investors to evaluate how Lifecore Biomedical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lifecore Biomedical shares will generate the highest return on investment. By understating and applying Lifecore Biomedical stock market price indicators, traders can identify Lifecore Biomedical position entry and exit signals to maximize returns.
Lifecore Biomedical Return and Market Media
The median price of Lifecore Biomedical for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 is 5.18 with a coefficient of variation of 15.55. The daily time series for the period is distributed with a sample standard deviation of 0.84, arithmetic mean of 5.38, and mean deviation of 0.69. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Lifecore Biomedical Inc. Is Being Sued For Possible Securities Law Infractions And The Schall Law Firm Invites Shareholder Participation | 08/29/2024 |
2 | Lifecore Biomedical to Participate in Craig-Hallum Bioprocessing Conference | 09/12/2024 |
3 | Lifecore Biomedical Board Changes Ahead of Annual Meeting - TipRanks | 09/23/2024 |
4 | The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Lifecore Biomedical, Inc. | 09/26/2024 |
5 | Lifecore Biomedical, Inc. Is Being Sued For Violating Securities Laws And Affected Shareholders Are Invited To Reach Out To The Schall Law Firm | 09/27/2024 |
6 | Acquisition by Kiper Christopher S of 152102 shares of Lifecore Biomedical at 4.1 subject to Rule 16b-3 | 10/03/2024 |
7 | Lifecore Biomedical Raises 24.3 Million in Private Placement of Common Stock | 10/04/2024 |
8 | Mondays Top Insider Moves Notable Buys and Sells in US Stocks | 10/08/2024 |
9 | Lifecore Biomedical GAAP EPS of -0.53, revenue of 24.7M | 10/11/2024 |
10 | Lifecore Biomedical Trading Up 4.5 percent - Time to Buy - MarketBeat | 11/07/2024 |
11 | Heres Why Greenhaven Road Capital Invested in Lifecore Biomedical - Insider Monkey | 11/15/2024 |
About Lifecore Biomedical Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Lifecore or other stocks. Alpha measures the amount that position in Lifecore Biomedical has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2010 | 2024 (projected) | null | 88.65 | 46.7 | null | 3.18 | 0.7 |
Lifecore Biomedical Upcoming Company Events
As portrayed in its financial statements, the presentation of Lifecore Biomedical's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Lifecore Biomedical's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Lifecore Biomedical's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Lifecore Biomedical. Please utilize our Beneish M Score to check the likelihood of Lifecore Biomedical's management manipulating its earnings.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 6th of June 2024 Next Financial Report | View | |
| 30th of November 2023 Next Fiscal Quarter End | View | |
| 29th of August 2024 Next Fiscal Year End | View | |
| 31st of August 2023 Last Quarter Report | View | |
| 31st of May 2023 Last Financial Announcement | View |
Build Portfolio with Lifecore Biomedical
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Lifecore Stock Analysis
When running Lifecore Biomedical's price analysis, check to measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.